Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis

The objective of this retrospective cohort study was to determine the effect of tumor necrosis factor inhibitor (TNFi) therapy on the risk of head and neck cancer (HNC) recurrence or HNC-attributable death in patients with rheumatoid arthritis (RA). RA patients with HNC were assembled from the US na...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Christopher, Zeringue, Angelique L., McDonald, Jay R., Eisen, Seth A., Ranganathan, Prabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658068/
https://www.ncbi.nlm.nih.gov/pubmed/26599370
http://dx.doi.org/10.1371/journal.pone.0143286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658068/
https://www.ncbi.nlm.nih.gov/pubmed/26599370
http://dx.doi.org/10.1371/journal.pone.0143286

Ejemplares similares